Last week, the New York Times published an article about a U.S. government complaint that Johnson & Johnson paid kickbacks to the biggest nursing home pharmacy in the U.S. to increase prescriptions of the antipsychotic Risperdal and other drugs. On her blog ElderCareTalk, Laura Bramly has posted a great analysis of what this means for people whose family members are in memory care units.
« From AA to AD, A Wistful Travelogue: Book Review | Main | MCI Symposium: Memory Loss and Exercise »
January 20, 2010
TrackBack
TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00d83451d58669e20120a7f1f4ad970b
Listed below are links to weblogs that reference Johnson & Johnson Risperdal Kickback Allegations:
Verify your Comment
Previewing your Comment
This is only a preview. Your comment has not yet been posted.
Your comment could not be posted. Error type:
Your comment has been saved. Comments are moderated and will not appear until approved by the author. Post another comment
As a final step before posting your comment, enter the letters and numbers you see in the image below. This prevents automated programs from posting comments.
Having trouble reading this image? View an alternate.
Legal Stuff
- Inclusion of links, advertisements and content generated by others does not imply endorsement. Remember, nothing on this site is meant as a substitute for professional medical advice or for using your own judgment!
Comments